serw-MX [xml]
 
 


 
check
 

0.36 /SANGUE . 
0.22 LDL-COLESTEROL .
0.16 HIPERCOLESTEROLEMIA .
0.13 COLESTEROL .
0.13 /FARMACOLOGIA .

Rank Sim. Fonte Título, abstract e conceitos DeCS   Conceitos DeCS em LILACS 
1 0.48 LILACS Cálculo de la concentración de colesterol de la lipoproteína de baja densidad: análisis de regresión versus fórmula de Friedewald . 
LDL-COLESTEROL; /SANGUE; HIPERCOLESTEROLEMIA; /DIAGNOSTICO .
Background: The Friedewald formula is used to estimate cholesterol of low density lipoprotein (LDL) from total cholesterol (CT), cholesterol of high density lipoprotein (HDL) and triglycerides (TG), but there are doubts about its precision Aim: To compare Friedewald formula and regression analysis for the calculation of LDL cholesterol Material and methods: One hundred and fifty plasma samples fro .. underestimation of LDL concentration by the Friedewald formula despite normal range of TG concentration A multiple regression analysis should be used to estimate LDL concentration with precision (AU) .
  0.37 LDL-COLESTEROL . 
0.24 /ANALISE .
0.15 /SANGUE .
0.12 /DIAGNOSTICO .
0.12 HIPERCOLESTEROLEMIA .
2 0.45 LILACS Alteraçoes do perfil lipídico na evolução tardia após transplante cardíaco . 
COLESTEROL; /SANGUE; TRANSPLANTE DE CORACAO; HDL-COLESTEROL; /SANGUE; LDL-COLESTEROL; /SANGUE; VLDL-COLESTEROL; /SANGUE; TRIGLICERIDEOS; /SANGUE .
PURPOSE: The aim of this study was to determine the lipid profile after heart transplantation METHODS: We performed sequential analyses in serum (in mg/dL) of total cholesterol, HDL-cholesterol, LDL-cholesterol, VLDL-cholesterol and triglycerides in patients who underwent orthotopic heart transplantation These analyses were performed at one month (33 patients), six months (32), one year (26), two .. - 15 at the 3rd year, p = ns) CONCLUSION: We observed a progressive elevation in the levels of total cholesterol, LDL, VLDL and triglicerides during the 1st three years after heart transplantation(Au) .

  0.55 /SANGUE . 
0.12 COLESTEROL .
0.12 HDL-COLESTEROL .
0.11 LDL-COLESTEROL .
0.09 TRIGLICERIDEOS .
3 0.44 LILACS Cholesterol-lowering effects of policosanol in rabbits . 
ANTICOLESTEROLEMIANTES; /FARMACOLOGIA; COLESTEROL; /SANGUE; ALCOOIS GRAXOS; /FARMACOLOGIA .
Policosanol is a natural mixture of higher primary aliphatic alcohols isolated and purified from sugar cane (Saccharum officinarum, L) wax, whose main component is octacosanol Policosanol (5-200 mg/kg) orally administered for 4 weeks to normocholesterolemic New Zealand rabbits significantly reduced total cholesterol and low density lipoprotein cholesterol (LDL-C) serum levels in a dose dependent m .. oprotein cholesterol (HDL-C) levels remained unchanged Results indicate that the reduction in total cholesterol values induced by policosanol is mainly mediated through a decrease in LDL-C levels (Au) .

  0.35 /FARMACOLOGIA . 
0.20 /SANGUE .
0.16 ANTICOLESTEROLEMIANTES .
0.15 COLESTEROL .
0.14 ALCOOIS GRAXOS .
4 0.43 LILACS Effect of a cholesterol-rich diet on the metabolism of the free and esterified cholesterol components of a nanoemulsion that resembles LDL in rabbits . 
ATEROSCLEROSE; /METABOLISMO; COLESTEROL; /FARMACOCINETICA; ESTERES DO COLESTEROL; /FARMACOCINETICA; HIPERLIPIDEMIAS; /METABOLISMO; LIPOPROTEINAS LDL; /SANGUE .
We have shown that the free cholesterol (FC) and the cholesteryl ester (CE) moieties of a nanoemulsion with lipidic structure resembling low-density lipoproteins show distinct metabolic fate in subjects and that this may be related to the presence of dyslipidemia and atherosclerosis The question was raised whether induction of hyperlipidemia and atherosclerosis in rabbits would affect the metaboli .. 07 percent/g; P < 005) Therefore, whereas in controls, FC and CE have similar metabolism, the induction of dyslipidemia and atherosclerosis resulted in dissociation of the two forms of cholesterol(AU) .

  0.51 /METABOLISMO . 
0.15 COLESTEROL .
0.12 /FARMACOLOGIA .
0.11 /FARMACOCINETICA .
0.11 LIPOPROTEINAS LDL .
5 0.42 LILACS Hipercolesterolemia familiar heterocigota: diagnóstico molecular y terapia combinada Caso clínico . 
HIPERCOLESTEROLEMIA; /QUIMIOTERAPIA; HIPERCOLESTEROLEMIA; /GENETICA .
Heterozygous familial hypercholesterolemia affects one every 400 individuals, is caused by mutations in the LDL receptor gene and is associated with premature coronary artery disease Nowadays, LDL cholesterol can be efficiently reduced with the new therapies to reduce blood lipids We report a female patient who consulted in 1975, when she was 46 years old, for severe hypercholesterolemia In 2003, .. No mutations in the apolipoprotein B gene were found The patient was treated successfully with simvastatin 80 mg/day and ezetimibe 10 mg/day and LDL cholesterol levels were reduced below 200 mg/dl(AU) .

  0.54 HIPERCOLESTEROLEMIA . 
0.15 /QUIMIOTERAPIA .
0.12 /USO TERAPEUTICO .
0.09 LDL-COLESTEROL .
0.09 /TERAPIA .
6 0.41 LILACS Aplicabilidad de la fórmula de Friedewald y de un método de precipitación en la determinación del LDL colesterol . 

  0.48 LDL-COLESTEROL . 
0.20 /ANALISE .
0.14 /SANGUE .
0.10 ATEROSCLEROSE .
0.09 METODOS .
7 0.40 LILACS Policosanol inhibits cholesterol biosynthesis and enhances low density lipoprotein processing in cultured human fibroblasts . 
ANTICOLESTEROLEMIANTES; /FARMACOLOGIA; COLESTEROL; /BIOSSINTESE; ALCOOIS GRAXOS; /FARMACOLOGIA; FIBROBLASTOS; /EFEITOS DE DROGAS; FIBROBLASTOS; /METABOLISMO; LIPOPROTEINAS LDL; /METABOLISMO .
Policosanol is a mixture of aliphatic primary alcohols isolated and purified from sugar cane wax, that induces cholesterol-lowering effects in experimental models and human beings When human lung fibroblasts were incubated with policosanol for 48 hours prior to the experiment, a dose dependent inhibition of 14C-acetate incorporation into total cholesterol was observed, whereas labeled mevalonate i .. processing may be partially explained by the inhibition of cholesterol biosynthesis, even though an sterol-independent mechanism might be responsible for the enhancement of LDL-receptor activity (Au) .

  0.33 /METABOLISMO . 
0.25 /FARMACOLOGIA .
0.18 COLESTEROL .
0.14 /EFEITOS DE DROGAS .
0.11 FIBROBLASTOS .
8 0.39 LILACS Nuevas normas de conducta para el tratamiento de la hipercolesterolemia en adultos . 
Extracta las partes más importantes del reporte Adult Treatment Panel III, del National Cholesterol Education Programe I, que introduce una importante serie de modificaciones, dándole importancia a cambios en el estilo de vida e intensificando los aspectos nutricionales, la actividad física, y el control de peso .

  0.47 HIPERCOLESTEROLEMIA . 
0.17 /TERAPIA .
0.15 LDL-COLESTEROL .
0.13 /PREVENCAO & CONTROLE .
0.08 /DIAGNOSTICO .
9 0.39 LILACS Relación colesterol total a HDL y colesterol no HDL: los mejores indicadores lipídicos de aumento de grosor de la íntima media carotidea . 
ATEROSCLEROSE; /SANGUE; ARTERIAS CAROTIDAS; /ULTRASSONOGRAFIA; ESPESSURA INTIMA-MEDIA CAROTIDEA; HDL-COLESTEROL; /SANGUE; LDL-COLESTEROL; /SANGUE .
Background: LDL, HDL cholesterol and triglycerides, are the most commonly used lipid cardiovascular risk predictor indicators However population based studies have shown that non-HDL cholesterol and total/HDL cholesterol ratio are better predictors, are easy to measure and do not require fasting Aim: To determine which lipid indicators are better determinants of subclinical atherosclerosis, measur .. having an IMT over the 75th percentile (odds ratio 121, 95% confidence intervals 109-135, p < 001) Conclusions: Total/HDL cholesterol ratio was the best determinant of subclinical atherosclerosis(AU) .

  0.50 /SANGUE . 
0.18 HDL-COLESTEROL .
0.12 LDL-COLESTEROL .
0.12 ATEROSCLEROSE .
0.09 COLESTEROL .
10 0.39 LILACS Comparação analítica de valores de LDL-colesterol utilizando a dosagem direta e o cálculo pela fórmula de Friedewald . 
LDL-COLESTEROL; ATEROSCLEROSE; DISLIPIDEMIAS; LDL-COLESTEROL; /ANALISE .
A avaliação fidedigna do perfil lipídico dos pacientes é fator fundamental para acompanhamento e prevenção das patologias cardiovasculares A proposta deste trabalho é avaliar o desempenho de dois métodos para dosagem do LDL-colesterol, um método direto e o método indireto pela fórmula de Friedewald, em uma população heterogênea Para tal foram realizadas dosagens de triglicerídeos, colesterol total .. as metodologias empregadas Este trabalho demonstrou que resultados de LDL-colesterol utilizando a fórmula de Friedewald e a medida direta não são idênticos com diferentes níveis de triglicerídeos(AU) .

  0.40 LDL-COLESTEROL . 
0.18 /ANALISE .
0.17 ATEROSCLEROSE .
0.14 DISLIPIDEMIAS .
0.12 /SANGUE .